Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steffen

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 3, 2005
Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery diseaseSamer S Najjar, Paul A Bottomley, Steven P Schulman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking propertiesS J Haleen, R P Steffen, I Sircar, et al.
Radiation Research|August 14, 2001
Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13G P Amorino, H Lee, G E Holburn, et al.
Journal of Medicinal Chemistry|August 1, 1988
2-(2-Aryl-2-oxoethylidene)-1,2,3,4-tetrahydropyridines. Novel isomers of 1,4-dihydropyridine calcium channel blockersM D Taylor, E W Badger, R P Steffen, et al.
Der Anaesthesist|January 4, 2006
[Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain]W Seeling, L Kneer, B Büchele, et al.
Journal of Medicinal Chemistry|February 1, 1989
Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failureI Sircar, R P Steffen, G Bobowski, et al.
Radiation Research|July 20, 2007
The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in miceHuagang Hou, Nadeem Khan, Oleg Y Grinberg, et al.
Journal of Medicinal Chemistry|August 1, 1985
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship applicationH W Hamilton, D F Ortwine, D F Worth, et al.
Circulation|May 1, 1993
Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failureH N Sabbah, F Hansen-Smith, V G Sharov, et al.
Journal of Medicinal Chemistry|July 1, 1991
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationshipsI Sircar, E K Gregor, K R Anderson, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 3, 2005
Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery diseaseSamer S Najjar, Paul A Bottomley, Steven P Schulman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking propertiesS J Haleen, R P Steffen, I Sircar, et al.
Radiation Research|August 14, 2001
Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13G P Amorino, H Lee, G E Holburn, et al.
Journal of Medicinal Chemistry|August 1, 1988
2-(2-Aryl-2-oxoethylidene)-1,2,3,4-tetrahydropyridines. Novel isomers of 1,4-dihydropyridine calcium channel blockersM D Taylor, E W Badger, R P Steffen, et al.
Der Anaesthesist|January 4, 2006
[Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain]W Seeling, L Kneer, B Büchele, et al.
Journal of Medicinal Chemistry|February 1, 1989
Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failureI Sircar, R P Steffen, G Bobowski, et al.
Radiation Research|July 20, 2007
The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in miceHuagang Hou, Nadeem Khan, Oleg Y Grinberg, et al.
Journal of Medicinal Chemistry|August 1, 1985
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship applicationH W Hamilton, D F Ortwine, D F Worth, et al.
Circulation|May 1, 1993
Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failureH N Sabbah, F Hansen-Smith, V G Sharov, et al.
Journal of Medicinal Chemistry|July 1, 1991
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationshipsI Sircar, E K Gregor, K R Anderson, et al.
Pageof 10